Latest Bevacizumab Stories
ResearchMoz.us include new market research report "Ovarian Cancer Therapeutics to 2020" to its huge collection of research reports.
Roche/Genentech's Avastin Continues to Garner the Greatest Physician-Reported Patient Share in DME Due to Its Low Relative Cost, According to Findings from Decision Resources Group BURLINGTON,
LONDON, May 5, 2014 /PRNewswire/ -- Reportbuyer.com has added a new market research report:
SAN DIEGO, May 5, 2014 /PRNewswire/ -- MEI Pharma, Inc.
MM-398 in Combination with 5-FU and Leucovorin Provides New Treatment Option for Patients Previously Treated with Gemcitabine MANHATTAN BEACH, Calif., May 1, 2014 /PRNewswire/ --
INDIANAPOLIS, April 21, 2014 /PRNewswire/ -- Eli Lilly and Company (NYSE: LLY) announced today that the U.S.
VAL-083 therapy is well tolerated to date; dose limiting toxicity has not been reached after fifth cohort (20mg/m2) VANCOUVER, British Columbia and MENLO PARK, Calif., April 9, 2014 /PRNewswire/
New research report “Biosimilar Index: Tracking the Global Biosimilar Pipeline” worked out by FirstWord is now available at MarketPublishers.com London,
The Most Promising Emerging Agents in Development for Triple Negative Breast Cancer Target Only Specific Patient Subsets, According to Findings from Decision Resources Group BURLINGTON, Mass.,
LONDON, April 3, 2014 /PRNewswire/ -- Reportbuyer.com just published a new market research report:
- The analysis of literature, focusing on the words and grammar to the exclusion of context or literary merit.